Selected research
Industry Research
Biotechnology Contract Manufacturing Industry Research Report 2026
Market perspective
The global Biotechnology Contract Manufacturing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Biotechnology Contract Manufacturing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Biotechnology Contract Manufacturing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Biotechnology Contract Manufacturing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Biotechnology Contract Manufacturing include Lonza, Thermo Fisher Scientific, Inc., Catalent, Inc., Samsung Biologics, WuXi Biologics, Boehringer Ingelheim International GmbH, FUJIFILM Holding Corporation, AbbVie, Inc. and Eurofins Scientific, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Biotechnology Contract Manufacturing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Biotechnology Contract Manufacturing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biotechnology Contract Manufacturing Market by Company
Lonza
Thermo Fisher Scientific, Inc.
Catalent, Inc.
Samsung Biologics
WuXi Biologics
Boehringer Ingelheim International GmbH
FUJIFILM Holding Corporation
AbbVie, Inc.
Eurofins Scientific
AGC, Inc.
Merck KgaA
Biotechnology Contract Manufacturing Segment by Type
Biologic Drug Substance Manufacturing
Biologic Drug Product Manufacturing
Biotechnology Contract Manufacturing Segment by Application
Monoclonal Antibodies
Cell Therapy & Gene Therapy
Antibody-Drug Conjugates (ADCs)
Vaccines
Therapeutic Peptides & Proteins
Others
Biotechnology Contract Manufacturing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biotechnology Contract Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biotechnology Contract Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biotechnology Contract Manufacturing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biotechnology Contract Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Biologic Drug Substance Manufacturing
- Biologic Drug Product Manufacturing
Applications
- Monoclonal Antibodies
- Cell Therapy & Gene Therapy
- Antibody-Drug Conjugates (ADCs)
- Vaccines
- Therapeutic Peptides & Proteins
- Others
Companies covered
- Lonza
- Thermo Fisher Scientific, Inc.
- Catalent, Inc.
- Samsung Biologics
- WuXi Biologics
- Boehringer Ingelheim International GmbH
- FUJIFILM Holding Corporation
- AbbVie, Inc.
- Eurofins Scientific
- AGC, Inc.
- Merck KgaA
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biotechnology Contract Manufacturing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Biologic Drug Substance Manufacturing
- 2.2.3 Biologic Drug Product Manufacturing
- 2.3 Biotechnology Contract Manufacturing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Monoclonal Antibodies
- 2.3.3 Cell Therapy & Gene Therapy
- 2.3.4 Antibody-Drug Conjugates (ADCs)
- 2.3.5 Vaccines
- 2.3.6 Therapeutic Peptides & Proteins
- 2.3.7 Others
- 2.4 Assumptions and Limitations
3 Biotechnology Contract Manufacturing Breakdown Data by Type
- 3.1 Global Biotechnology Contract Manufacturing Historic Market Size by Type (2021-2026)
- 3.2 Global Biotechnology Contract Manufacturing Forecasted Market Size by Type (2027-2032)
4 Biotechnology Contract Manufacturing Breakdown Data by Application
- 4.1 Global Biotechnology Contract Manufacturing Historic Market Size by Application (2021-2026)
- 4.2 Global Biotechnology Contract Manufacturing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Biotechnology Contract Manufacturing Market Perspective (2021-2032)
- 5.2 Global Biotechnology Contract Manufacturing Growth Trends by Region
- 5.2.1 Global Biotechnology Contract Manufacturing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Biotechnology Contract Manufacturing Historic Market Size by Region (2021-2026)
- 5.2.3 Biotechnology Contract Manufacturing Forecasted Market Size by Region (2027-2032)
- 5.3 Biotechnology Contract Manufacturing Market Dynamics
- 5.3.1 Biotechnology Contract Manufacturing Industry Trends
- 5.3.2 Biotechnology Contract Manufacturing Market Drivers
- 5.3.3 Biotechnology Contract Manufacturing Market Challenges
- 5.3.4 Biotechnology Contract Manufacturing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Biotechnology Contract Manufacturing Players by Revenue
- 6.1.1 Global Top Biotechnology Contract Manufacturing Players by Revenue (2021-2026)
- 6.1.2 Global Biotechnology Contract Manufacturing Revenue Market Share by Players (2021-2026)
- 6.2 Global Biotechnology Contract Manufacturing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Biotechnology Contract Manufacturing Head Office and Area Served
- 6.4 Global Biotechnology Contract Manufacturing Players, Product Type & Application
- 6.5 Global Biotechnology Contract Manufacturing Manufacturers Established Date
- 6.6 Global Biotechnology Contract Manufacturing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Biotechnology Contract Manufacturing Market Size (2021-2032)
- 7.2 North America Biotechnology Contract Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Biotechnology Contract Manufacturing Market Size by Country (2021-2026)
- 7.4 North America Biotechnology Contract Manufacturing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Biotechnology Contract Manufacturing Market Size (2021-2032)
- 8.2 Europe Biotechnology Contract Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Biotechnology Contract Manufacturing Market Size by Country (2021-2026)
- 8.4 Europe Biotechnology Contract Manufacturing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Biotechnology Contract Manufacturing Market Size (2021-2032)
- 9.2 Asia-Pacific Biotechnology Contract Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Biotechnology Contract Manufacturing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Biotechnology Contract Manufacturing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Biotechnology Contract Manufacturing Market Size (2021-2032)
- 10.2 South America Biotechnology Contract Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Biotechnology Contract Manufacturing Market Size by Country (2021-2026)
- 10.4 South America Biotechnology Contract Manufacturing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Biotechnology Contract Manufacturing Market Size (2021-2032)
- 11.2 Middle East & Africa Biotechnology Contract Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Biotechnology Contract Manufacturing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Biotechnology Contract Manufacturing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Lonza
- 12.1.1 Lonza Company Information
- 12.1.2 Lonza Business Overview
- 12.1.3 Lonza Revenue in Biotechnology Contract Manufacturing Business (2021-2026)
- 12.1.4 Lonza Biotechnology Contract Manufacturing Product Portfolio
- 12.1.5 Lonza Recent Developments
- 12.2 Thermo Fisher Scientific, Inc.
- 12.2.1 Thermo Fisher Scientific, Inc. Company Information
- 12.2.2 Thermo Fisher Scientific, Inc. Business Overview
- 12.2.3 Thermo Fisher Scientific, Inc. Revenue in Biotechnology Contract Manufacturing Business (2021-2026)
- 12.2.4 Thermo Fisher Scientific, Inc. Biotechnology Contract Manufacturing Product Portfolio
- 12.2.5 Thermo Fisher Scientific, Inc. Recent Developments
- 12.3 Catalent, Inc.
- 12.3.1 Catalent, Inc. Company Information
- 12.3.2 Catalent, Inc. Business Overview
- 12.3.3 Catalent, Inc. Revenue in Biotechnology Contract Manufacturing Business (2021-2026)
- 12.3.4 Catalent, Inc. Biotechnology Contract Manufacturing Product Portfolio
- 12.3.5 Catalent, Inc. Recent Developments
- 12.4 Samsung Biologics
- 12.4.1 Samsung Biologics Company Information
- 12.4.2 Samsung Biologics Business Overview
- 12.4.3 Samsung Biologics Revenue in Biotechnology Contract Manufacturing Business (2021-2026)
- 12.4.4 Samsung Biologics Biotechnology Contract Manufacturing Product Portfolio
- 12.4.5 Samsung Biologics Recent Developments
- 12.5 WuXi Biologics
- 12.5.1 WuXi Biologics Company Information
- 12.5.2 WuXi Biologics Business Overview
- 12.5.3 WuXi Biologics Revenue in Biotechnology Contract Manufacturing Business (2021-2026)
- 12.5.4 WuXi Biologics Biotechnology Contract Manufacturing Product Portfolio
- 12.5.5 WuXi Biologics Recent Developments
- 12.6 Boehringer Ingelheim International GmbH
- 12.6.1 Boehringer Ingelheim International GmbH Company Information
- 12.6.2 Boehringer Ingelheim International GmbH Business Overview
- 12.6.3 Boehringer Ingelheim International GmbH Revenue in Biotechnology Contract Manufacturing Business (2021-2026)
- 12.6.4 Boehringer Ingelheim International GmbH Biotechnology Contract Manufacturing Product Portfolio
- 12.6.5 Boehringer Ingelheim International GmbH Recent Developments
- 12.7 FUJIFILM Holding Corporation
- 12.7.1 FUJIFILM Holding Corporation Company Information
- 12.7.2 FUJIFILM Holding Corporation Business Overview
- 12.7.3 FUJIFILM Holding Corporation Revenue in Biotechnology Contract Manufacturing Business (2021-2026)
- 12.7.4 FUJIFILM Holding Corporation Biotechnology Contract Manufacturing Product Portfolio
- 12.7.5 FUJIFILM Holding Corporation Recent Developments
- 12.8 AbbVie, Inc.
- 12.8.1 AbbVie, Inc. Company Information
- 12.8.2 AbbVie, Inc. Business Overview
- 12.8.3 AbbVie, Inc. Revenue in Biotechnology Contract Manufacturing Business (2021-2026)
- 12.8.4 AbbVie, Inc. Biotechnology Contract Manufacturing Product Portfolio
- 12.8.5 AbbVie, Inc. Recent Developments
- 12.9 Eurofins Scientific
- 12.9.1 Eurofins Scientific Company Information
- 12.9.2 Eurofins Scientific Business Overview
- 12.9.3 Eurofins Scientific Revenue in Biotechnology Contract Manufacturing Business (2021-2026)
- 12.9.4 Eurofins Scientific Biotechnology Contract Manufacturing Product Portfolio
- 12.9.5 Eurofins Scientific Recent Developments
- 12.10 AGC, Inc.
- 12.10.1 AGC, Inc. Company Information
- 12.10.2 AGC, Inc. Business Overview
- 12.10.3 AGC, Inc. Revenue in Biotechnology Contract Manufacturing Business (2021-2026)
- 12.10.4 AGC, Inc. Biotechnology Contract Manufacturing Product Portfolio
- 12.10.5 AGC, Inc. Recent Developments
- 12.11 Merck KgaA
- 12.11.1 Merck KgaA Company Information
- 12.11.2 Merck KgaA Business Overview
- 12.11.3 Merck KgaA Revenue in Biotechnology Contract Manufacturing Business (2021-2026)
- 12.11.4 Merck KgaA Biotechnology Contract Manufacturing Product Portfolio
- 12.11.5 Merck KgaA Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst